For creating a small-molecule drug, researchers developed a large-scale synthesis method for easily developing a compound necessary for IBD treatment.
Scientists at the Institut Pasteur discovered innate effector cells active in early infection that can also be trained to “remember” that disease and protect the host from reinfection.
A recent mouse study suggests a reason behind colitis is the activation of a receptor that promotes inflammation and pain.
People with IBD have shown a reduced diversity in their gut microbiome with notable decreases among Bacteroides and Firmicutes bacteria.
Study results point to a promising future for opioids when it comes to treatment of inflammatory bowel disease and other gut ailments.
New research suggests small proteins called IL-36 cytokines may be a critical target for treating childhood inflammatory bowel disease (IBD).
A group of microbial enzymes living in the gut microbiome were found to be the culprit behind ulcerative colitis.
Swedish and German researchers find that a modern biological change to a protein in the human body protects individuals from oxidative stress that causes vascular diseases and inflammatory bowel disease (IBS).
New research from scientists at the Technical University of Munich suggests one cause of IBD is the bacteria living in the gut microbiome.
Triclosan, an antibacterial present in toothpaste, toys, and dozens of other goods, has been shown to cause gut inflammation in mice, according to recent research.